Year in Review Rheumatoid Arthritis

Year in Review Rheumatoid Arthritis

Year in Review: Rheumatoid Arthritis

Take a look back at the most popular Rheumatoid Arthritis articles of 2018


Custom drug update image

Biosimilar Hyrimoz Gains FDA Approval

The FDA’s approval was supported by data from analytical, preclinical, and clinical research showing that Hyrimoz matched the reference product’s safety, efficacy, and quality.